REGN

Regeneron Pharmaceuticals
D

REGN

747.30
USD
4.53
(0.61%)
Market Open
Volume
18,717
EPS
45
Div Yield
-
P/E
20
Market Cap
82,528,182,481
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    ABBV
    -4.630
    (-2.73%)
    171.825 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    290.54 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.86 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    751.41 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    103.62 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    24.96 USD
    More
News

Title: Regeneron Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Regeneron Pharmaceuticals Inc. is an integrated biotechnology firm. The company was founded in 1988 and is headquartered in Tarrytown, New York. It develops, manufactures and sells medicines for serious conditions such as eye diseases, allergy and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and more. Its product line includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST and ZALTRAP. The company was founded by Alfred G. Gilman, Leonard S. Schleifer and Eric M. Shooter on January 8, 1988.